These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 20026848)

  • 21. Treatment of primary cutaneous anaplastic large cell lymphoma with superficial x-rays.
    Jepsen ME; Gniadecki R
    Dermatol Reports; 2015 Mar; 7(1):5888. PubMed ID: 25918620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous anaplastic large cell lymphoma occurring in an atopic dermatitis patient: a case report with review of the literature with emphasis on their association.
    Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(4):1735-41. PubMed ID: 24817972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous anaplastic large-cell lymphoma--case report.
    Oliveira LS; Nobrega MP; Monteiro MG; Almeida WL
    An Bras Dermatol; 2013; 88(6 Suppl 1):132-5. PubMed ID: 24346900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periocular cutaneous anaplastic large cell lymphoma clearance with brentuximab vedotin.
    Kaffenberger BH; Kartono Winardi F; Frederickson J; Porcu P; Wong HK
    J Clin Aesthet Dermatol; 2013 Aug; 6(8):29-31. PubMed ID: 24003348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.
    Oschlies I; Lisfeld J; Lamant L; Nakazawa A; d'Amore ES; Hansson U; Hebeda K; Simonitsch-Klupp I; Maldyk J; Müllauer L; Tinguely M; Stücker M; Ledeley MC; Siebert R; Reiter A; Brugières L; Klapper W; Woessmann W
    Haematologica; 2013 Jan; 98(1):50-6. PubMed ID: 22773605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Pfaltz K; Vermeer MH; Cozzio A; Ortiz-Romero PL; Bagot M; Olsen E; Kim YH; Dummer R; Pimpinelli N; Whittaker S; Hodak E; Cerroni L; Berti E; Horwitz S; Prince HM; Guitart J; Estrach T; Sanches JA; Duvic M; Ranki A; Dreno B; Ostheeren-Michaelis S; Knobler R; Wood G; Willemze R
    Blood; 2011 Oct; 118(15):4024-35. PubMed ID: 21841159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.
    van Krieken JH
    J Hematop; 2010 Jun; 3(1):47-58. PubMed ID: 21633487
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.
    Woo DK; Jones CR; Vanoli-Storz MN; Kohler S; Reddy S; Advani R; Hoppe RT; Kim YH
    Arch Dermatol; 2009 Jun; 145(6):667-74. PubMed ID: 19528422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas.
    Tancrède-Bohin E; Ionescu MA; de La Salmonière P; Dupuy A; Rivet J; Rybojad M; Dubertret L; Bachelez H; Lebbé C; Morel P
    Arch Dermatol; 2004 Sep; 140(9):1057-61. PubMed ID: 15381544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma.
    Benner MF; Willemze R
    Arch Dermatol; 2009 Dec; 145(12):1399-404. PubMed ID: 20026848
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.